TY - JOUR T1 - A novel mutation in complement 2 accompanied by susceptibility variants in C3 glomerulonephritis: A case study JO - NefrologĂ­a T2 - AU - Han,Sha-sha AU - Yu,Xiao-juan AU - Wang,Su-xia AU - Zhou,Fu-de AU - Yu,Feng AU - Zhao,Ming-hui SN - 02116995 M3 - 10.1016/j.nefro.2019.01.008 DO - 10.1016/j.nefro.2019.01.008 UR - https://www.revistanefrologia.com/es-a-novel-mutation-in-complement-articulo-S0211699519300554 AB - BackgroundC3 glomerulonephritis is a rare, chronic disease characterized by C3c-dominant staining on renal biopsy and is caused by inherited or acquired alternative complement pathway dysregulation. Case presentationHere, we reported a 36-year-old man presenting with nephritic syndrome and normal renal function. Secondary causes were excluded by detailed clinical history and laboratory tests. His renal biopsy was consistent with C3 glomerulonephritis with a membranoproliferative glomerulonephritis pattern. To identify the etiology, we carried out genetic and autoantibody screening tests. The results showed he was negative for autoantibodies, while the next-generation sequencing revealed common variants of complement factor H (c.1204T>C; p.Tyr402His), (c.184G>A; p.Val62Ile) and thrombomodulin (c.1418C>T; p.Ala473Val), which have previously been reported to increase susceptibility to complement-mediated diseases. He also carried complement factor H (c.2808G>T; p.Glu936Asp) and mannose-binding lectin (c.161G>A; p.Gly54Asp), putting the patient at an increased risk of infections, which was an important trigger for C3 glomerulonephritis. A novel variant of complement 2 (c.53A>G; p.His18Arg) that might contribute to the occurrence of C3 glomerulonephritis when combined with these susceptibility variants was further identified. The patient was treated with ramipril and regular fresh frozen plasma infusion. He had a good response to treatment with well-controlled proteinuria, stable renal function and an increasing serum C3 level. ConclusionsThis case adds insight into the pathogenesis of C3 glomerulopathy by showing that a combination of susceptibility variants, genetic mutations and triggers might be responsible for the clinical and pathological phenotypes. ER -